Characterization of soluble thrombomodulin levels in patients with stage 3-5 chronic kidney disease

Biomarkers

Volumn 19, Issue 4, 2014, Pages 275-280

  Bao, Yu Shi ^a   Jia, Xi Bei ^a   Wang, Dong ^b   Liu, Rui Chan ^a   Zou, Chun Bo ^a   Na, Shi Ping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b Heilongjiang Academy of Traditional Chinese Medicine   (China)

Author keywords

Chronic kidney disease; Coagulation; Inflammation; Soluble thrombomodulin

Indexed keywords

CREATININE; THROMBOMODULIN;

ADULT; AGED; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DAMAGE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ELISA KIT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; THROMBOMODULIN BLOOD LEVEL; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; GLOMERULUS FILTRATION RATE; MIDDLE AGED; PATHOPHYSIOLOGY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROTHROMBIN TIME; THROMBOMODULIN; YOUNG ADULT;

EID: 84901380818     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2014.904000     Document Type: Article

References (26)

1. Abeyama K, Stern DM, Ito Y, et al. (2005). The N-Terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel anti-inflammatory mechanism. J Clin Invest 115:1267-74. (Pubitemid 40629045
2. Blann AD, McCollum CN. (1999). von Willebrand factor and soluble thrombomodulin as predictors of adverse events among subjects wiThperipheral or coronary atherosclerosis. Blood Coagul Fibrinolysis 10: 375-80. (Pubitemid 29416082
3. Conway EM. (2012). Thrombomodulin and its role in inflammation. Semin Immunopathol 34:107-25
4. Dittman WA, Majerus PW. (1990). Structure and function of thrombomodulin: A natural anticoagulant. Blood 75:329-36. (Pubitemid 20035260
5. Dohi Y, Ohashi M, Sugiyama M, et al. (2003). Circulating thrombomodulin levels are related to latent progression of atherosclerosis in hypertensive patients. Hypertens Res 26:479-83. (Pubitemid 36857067
6. Endemann DH, Schiffrin EL. (2004). Endothelial dysfunction. J Am Soc Nephrol 15:1983-92. (Pubitemid 39031337
7. Hung AM, Crawford DC, Griffin MR, et al. (2010). CRP polymorphisms and progression of chronic kidney disease in African Americans. Clin J Am Soc Nephrol 5:24-33
8. Ikeguchi H, Maruyama S, Morita Y, et al. (2002). Effects of human soluble thrombomodulin on experimental glomerulonephritis. Kidney Int 61:490-501. (Pubitemid 34102589
9. Kato S, Chmielewski M, Honda H, et al. (2008). Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3: 1526-33
10. Krychtiuk KA, Kastl SP, Speidl WS, Wojta J. (2013). Inflammation and coagulation in atherosclerosis. Hamostaseologie 33:269-82
11. Levey AS, Bosch JP, Lewis JB, et al. (1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-70. (Pubitemid 29135798
12. Li YH, Kuo CH, Shi GY, Wu HL. (2012). The role of thrombomodulin lectin-like domain in inflammation. J Biomed Sci 19:34
13. Maeda S, Takahashi S, Sato M. (2012). Serum thrombomodulin as a newly identified biomarker for postoperative lung injury: A prospective observational study. Tohoku J Exp Med 228:135-41
14. Morser J. (2012). Thrombomodulin links coagulation to inflammation and immunity. Current Drug Targets 13:421-31
15. National Kidney Foundation (NKF) Kidney Disease Outcome Quality Initiative (K/DOQI) Advisory board. (2002). K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 39:S1-246
16. Olechnowicz-Tietz S, Gluba A, Paradowska A, et al. (2013). The risk of atherosclerosis in patients wiThchronic kidney disease. Int Urol Nephrol 45:1605-12
17. Olivot JM, Labreuche J, Aiach M, Amarenco P, GENIC Investigators. (2004). Soluble thrombomodulin and brain infarction case-control and prospective study. Stroke 35:1946-51. (Pubitemid 38971881
18. Ozaki T, Anas C, Maruyama S, et al. (2008). Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure. Nephrol Dial Transplant 23:110-19. (Pubitemid 351767375
19. Rajashekhar G, Gupta A, Marin A, et al. (2012). Soluble thrombomodulin reduces inflammation and prevents microalbuminuria induced by chronic endothelial activation in transgenic mice. Am J Physiol Renal Physiol 302:F703-12
20. Salomaa V, Matei C, Aleksic N, et al. (2001). Cross-sectional association of soluble thrombomodulin wiThmild peripheral artery disease; the ARIC study. Atherosclerosis Risk in Communities. Atherosclerosis 157:309-14. (Pubitemid 32710009
21. Schiffrin EL, Lipman ML, Mann JF. (2007). Chronic kidney disease: Effects on the cardiovascular system. Circulation 116: 85-97. (Pubitemid 47016250
22. Sharain K, Hoppensteadt D, Bansal V, et al. (2013). Progressive increase of inflammatory biomarkers in chronic kidney disease and end-stage renal disease. Clin Appl Thromb Hemost 19:303-8
23. Sharfuddin AA, Sandoval RM, Berg DT, et al. (2009). Soluble thrombomodulin protects ischemic kidneys. J Am Soc Nephrol 20: 524-34
24. Tonelli M, Sacks F, Pfeffer M, et al. (2005). Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68:237-45. (Pubitemid 43181381
25. Van De Wouwer M, Plaisance S, De Vriese A, et al. (2006). The lectinlike domain of thrombomodulin interferes wiThcomplement activation and protects against arthritis. J Thromb Haemost 4:1813-24. (Pubitemid 44144810
26. Yerkovich ST, Roponen M, Smith ME, et al. (2009). Allergen-enhanced thrombomodulin (blood dendritic cell antigen 3, CD141) expression on dendritic cells is associated wiTha TH2-skewed immune response. J Allergy Clin Immunol 123:209-16